UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer

Frontiers in oncology, 2021-10, Vol.11, p.731535-731535

2021

Volltextzugriff (PDF)

Autophagy and doxorubicin resistance in cancer

Anti-cancer drugs, 2018-01, Vol.29 (1), p.1-9

2018

Volltextzugriff (PDF)

Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance

Breast cancer research : BCR, 2023-07, Vol.25 (1), p.88-88, Article 88

2023

Volltextzugriff (PDF)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives

Frontiers in oncology, 2021-05, Vol.11, p.648139-648139

2021

Volltextzugriff (PDF)

A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables

Scientific reports, 2022-11, Vol.12 (1), p.20374-20374, Article 20374

2022

Volltextzugriff (PDF)

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis

BMC cancer, 2019-08, Vol.19 (1), p.831-11, Article 831

2019

Volltextzugriff (PDF)

Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer

Molecular cancer, 2015-04, Vol.14 (1), p.73-73, Article 73

2015

Volltextzugriff (PDF)

Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer

Genes, 2023-12, Vol.14 (12), p.2172

2023

Volltextzugriff (PDF)

Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins

Frontiers in oncology, 2021-06, Vol.11, p.656687-656687

2021

Volltextzugriff (PDF)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy

Frontiers in oncology, 2022-11, Vol.12, p.1026566-1026566

2022

Volltextzugriff (PDF)

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells

Nanoscale research letters, 2019-09, Vol.14 (1), p.314-12, Article 314

2019

Volltextzugriff (PDF)

A bibliometric analysis of 16,826 triple-negative breast cancer publications using multiple machine learning algorithms: Progress in the past 17 years

Frontiers in medicine, 2023-02, Vol.10, p.999312-999312

2023

Volltextzugriff (PDF)

Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53 -Aberrant Triple-Negative Breast Cancer

Frontiers in oncology, 2022-02, Vol.12, p.804466-804466

2022

Volltextzugriff (PDF)

Recent advances in bone-targeted therapies of metastatic prostate cancer

Cancer treatment reviews, 2014-07, Vol.40 (6), p.730-738

2014

Volltextzugriff (PDF)

FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP

Mathematical biosciences and engineering : MBE, 2022-01, Vol.19 (9), p.9295-9320

2022

Volltextzugriff (PDF)

Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer

Frontiers in oncology, 2022-01, Vol.12, p.731528-731528

2022

Volltextzugriff (PDF)

KCTD10 is involved in the cardiovascular system and Notch signaling during early embryonic development

PloS one, 2014-11, Vol.9 (11), p.e112275-e112275

2014

Volltextzugriff (PDF)

Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma

PloS one, 2013-03, Vol.8 (3), p.e56114

2013

Volltextzugriff (PDF)

Adiponectin in Fresh Frozen Plasma Contributes to Restoration of Vascular Barrier Function After Hemorrhagic Shock

Shock (Augusta, Ga.), 2016-01, Vol.45 (1), p.50-54

2016

Volltextzugriff (PDF)

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12

The Prostate, 2006-01, Vol.66 (1), p.32-48

2006

Volltextzugriff (PDF)

Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL

PloS one, 2012-04, Vol.7 (4), p.e34912-e34912

2012

Volltextzugriff (PDF)

Adenovirus‐mediated expression of TIMP‐1 and TIMP‐2 in bone inhibits osteolytic degradation by human prostate cancer

International journal of cancer, 2008-01, Vol.122 (1), p.209-218

2008

Volltextzugriff (PDF)

Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases

Clinical & experimental metastasis, 2007-04, Vol.24 (2), p.107-119

2007

Volltextzugriff (PDF)

Triple-negative breast cancer: is there a treatment on the horizon?

Oncotarget, 2017-01, Vol.8 (1), p.1913-1924

2017

Volltextzugriff (PDF)

Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue

The American journal of pathology, 2005-04, Vol.166 (4), p.1173-1186

2005

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(115)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Cancer
(12)
Biochemical And Biophysical Research Communications
(6)
Frontiers In Oncology
(6)
Blood
(4)
Chinese Medical Journal
(4)
Plos One
(4)
Shock
(4)
Anti-Cancer Drugs
(3)
Advanced Science
(2)
Applied Catalysis. A, General
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer

Autophagy and doxorubicin resistance in cancer

Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives

A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis

Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer

Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer

Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells

A bibliometric analysis of 16,826 triple-negative breast cancer publications using multiple machine learning algorithms: Progress in the past 17 years

Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53 -Aberrant Triple-Negative Breast Cancer

Recent advances in bone-targeted therapies of metastatic prostate cancer

FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP

Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer

KCTD10 is involved in the cardiovascular system and Notch signaling during early embryonic development

Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma

Adiponectin in Fresh Frozen Plasma Contributes to Restoration of Vascular Barrier Function After Hemorrhagic Shock

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12

Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL

Adenovirus‐mediated expression of TIMP‐1 and TIMP‐2 in bone inhibits osteolytic degradation by human prostate cancer

Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases

Triple-negative breast cancer: is there a treatment on the horizon?

Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue

Suchergebnisse filtern